Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 108 clinical trials
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

The purpose of this study is to see if the study drug, romiplostim, helps low platelet count caused by standard chemotherapy treatment for lymphoma. This study will also look at whether

romiplostim
platelet count
cytarabine
neutrophil count
g-csf
  • 1 views
  • 14 Jul, 2022
  • 7 locations
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

The purpose of this study is to see if the study drug, romiplostim, helps low platelet count caused by the standard blood cancer treatment of chemotherapy and autologous hematopoietic cell

cell transplantation
chemotherapy regimen
hematologic malignancy
lymphoma
hodgkin's disease
  • 35 views
  • 11 Mar, 2022
  • 7 locations
Impact of the Platelet Level in Patients Treated for Glioblastoma With Temozolomid

variation in platelet count during the radio-chemotherapy phase. The main objective is to identify early in Stupp protocol a group of patients having high risk to undergo thrombocytopenia in maintenance

platelet count
temozolomide
  • 15 views
  • 24 Jan, 2021
  • 1 location
Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy (GOODHEART-ACLF)

, platelet count, etc. the other treated using a ROTEM-based algorithm. They will be followed for development of rebleeding, complications of transfusion and any signs of infection after hospitalization

prothrombin
hemostatic
  • 0 views
  • 14 May, 2022
  • 1 location
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)

The aim of this study is to improve treatment of Moderate Aplastic Anemia (MAA) by evaluating the safety and efficiency of Eltrombopag as a new treatment option in patients with therapy requiring MAA.

eltrombopag
blood transfusion
reticulocyte count
hypocellular bone marrow
neutrophil count
  • 78 views
  • 22 Jan, 2021
  • 1 location
Pharmacodynamic Effects and Predictive Biomarkers of Janus Kinases (JAK)/Signal Transducer and Activator of Transcription (STAT) Inhibition With Ruxolitinib in Operable Head and Neck Cancer: a Window Trial

The purpose of this study is to assess the safety and efficacy of ruxolitinib in patients with operable Head and neck squamous cell carcinoma (HNSCC) who are planned for definitive surgery.

human chorionic gonadotropin
squamous cell carcinoma
serum pregnancy test
head and neck cancer
neutrophil count
  • 4 views
  • 19 Oct, 2022
  • 2 locations
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

End stage liver disease is prone to thrombocytopenia. This study is a multi-center, randomized, prospective, randomized controlled Phase IV Clinical trial to discuss the Efficacy and Safety of Avatrombopag in Patients with End-stage Liver Disease and Thrombocytopenia.

platelet count
cirrhosis
avatrombopag
liver disease
  • 0 views
  • 16 Jun, 2021
  • 1 location
Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation (OPSTAHT)

This study is comparing the use of Kcentra vs. standard transfusion in patients undergoing heart transplantation surgery. Half of the patients will receive Kcentra, while the other half will receive fresh frozen plasma.

heart transplantation
  • 7 views
  • 23 Mar, 2022
  • 2 locations
The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Randomized, open-label, multicenter study to compare the efficacy and safety of Combination of High-dose Dexamethasone and Tacrolimus versus High-dose Dexamethasone for the first-line treatment of adults with primary immune thrombocytopenia (ITP).

  • 2 views
  • 18 Feb, 2021
  • 1 location
The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Randomized, open-label, multicenter study to compare the efficacy and safety of combination of Sitagliptin and danazol versus danazol for the treatment of adults with steroid-resistant/relapse immune thrombocytopenia (ITP).

danazol
corticosteroids
platelet count
thrombocytopenia
immune globulin
  • 0 views
  • 11 May, 2022
  • 1 location